Novartis Pharmaceuticals Corporation recalls Diovan
- Recalling company
- Novartis Pharmaceuticals Corporation
- Product
- Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
- Reason
- Failed Dissolution Specifications
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Aug 4, 2026
- Reported
- Aug 19, 2026
- Distribution
- US Nationwide
- Status
- Ongoing
- Lot / codes
- Lot AV5913C, Expiry: 6/2027
- Company location
- East Hanover, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0746-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0746-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.